000 03831cam a2200517 i 4500
999 _c200454473
_d72685
001 200454473
003 TR-AnTOB
005 20230926152807.0
006 m o d
007 cr cnu---unuuu
008 230820t20212021nju ob 001 0 eng
020 _a9781119432487
_q(e-book)
020 _a1119432480
_q(e-book)
020 _a9781119432494
_q(e-book)
020 _a1119432499
_q(e-book)
020 _a9781119432456
_q(e-book)
020 _a1119432456
_q(e-book)
020 _z9781119432449
_qhardcover
035 _a(OCoLC)1145092231
035 _a(TR-AnTOB)200454473
040 _aDLC
_beng
_erda
_cDLC
_dOCLCO
_dOCLCA
_dOCLCQ
_dDG1
_dOCLCF
_dYDX
_dTR-AnTOB
041 0 _aeng
060 1 0 _aQZ 269
_bP923 2021
096 _aQZ269
_bP923 2021EBK
245 0 0 _aPrecision medicine in oncology /
_cedited by James A. Radosevich, Bulent Aydogan.
264 1 _aHoboken, NJ :
_bWiley-Blackwell,
_c2021.
264 4 _c©2021
300 _a1 online resource (xxii, 249 pages)
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
504 _aBIBINDX
505 0 _aGenomic Strategies for Personalized Cancer Therapy -- Blood-based biomarkers for the diagnosis and prognosis of cancer -- Application of circulating cell free DNA for personalized cancer therapy -- Prognostic Implications of EGFR, p53, p16, cyclin D1, Bcl-2 in Head & Neck Squamous Cell Carcinoma (HNSCC) -- Predictive and prognostic markers for cancer medicine -- Dual Energy Imaging in Precision Radiation Therapy -- The role of Big Data in personalized medicine
520 _a"Most medical treatments have been designed for the "average patient." As a result of this "one-size-fits-all-approach," treatments can be very successful for some patients but not for others. This is changing with the emergence of precision medicine, an innovative approach to disease prevention and treatment that takes into account individual differences in people's genes, environments, and lifestyles. Precision medicine gives clinicians tools to better understand the complex mechanisms underlying a patient's health, disease, or condition, and to better predict which treatments will be most effective. Precision or personalized medicine in cancer treatment was once a buzzword, but it is finally becoming a reality with recent advances in imaging, genetic, and biological sciences. The importance of interpatient and intratumor variability has long been recognized, but realistic opportunities to take these into account in cancer care have emerged only recently. Innovations in patient characterization through genomics, proteomics, and metabolomics have opened new avenues to personalize cancer treatment in ways that were not possible before. Furthermore, advances in quantitative assessment of therapeutic response, as provided by functional and molecular imaging, have been critical in the implementation of precision medicine paradigm in radiation oncology. This book will be a comprehensive review of science and technology making precision medicine possible for radiation oncology, current examples and future direction"--
_cProvided by publisher
650 0 _aCancer
_xRadiotherapy
650 1 2 _aNeoplasms
_xradiotherapy
_9143654
650 2 2 _aPrecision Medicine
_xmethods
_9143655
655 0 _aElectronic books
_92032
700 1 _aRadosevich, James A.
_q(James Andrew)
_eeditor
_9143656
700 1 _aAydoğan, Bülent
_eeditor
_9143657
776 0 8 _iPrint version:
_tPrecision medicine in oncology
_dHoboken, NJ : Wiley-Blackwell, 2021.
_z9781119432449
_w(DLC) 2020012104
856 4 0 _3Wiley Online Library
_zOnline access link to the resource
_uhttps://onlinelibrary.wiley.com/doi/book/10.1002/9781119432487
942 _2NLM
_cEBK